Navigation Links
Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
Date:4/5/2011

MISSISSAUGA, Ontario, April 5, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has filed with the Securities and Exchange Commission (SEC) a preliminary consent solicitation statement in connection with its solicitation of written consents from the Cephalon stockholders to remove each member of the Board of Directors of Cephalon Inc. ("Cephalon") and elect seven new directors in their place. The proposed directors are:

  • Santo J. Costa, Former President and COO of Quintiles
  • Richard H. Koppes, Former General Counsel and Interim CEO of CalPERS
  • Lawrence N. Kugelman, Former CEO and President of Coventry Health Care
  • Anders Lonner, Group President and CEO of Meda AB
  • John H. McArthur, Former Dean of Harvard Business School
  • Thomas G. Plaskett, Director of Alcon and RadioShack
  • Blair H. Sheppard, Chair and former CEO of Duke Corporate Education and former Dean of Fuqua School of Business, Duke University

Today Cephalon formally rejected Valeant's offer.  Therefore, Valeant is going directly and immediately to Cephalon stockholders by initiating its consent solicitation process. It is Valeant's expectation that a new Cephalon board would act in the best interests of Cephalon stockholders and remove the impediments to a tender offer, such as the poison pill, and permit Valeant to conduct a due diligence investigation. As stated before, such a due diligence investigation could enable Valeant to modestly increase its offer price, if the results of such investigate demonstrate that additional value exists. In short, Valeant is committed to enabling stockholders to decide whether to accept this offer.

J. Michael Pearson, Valeant's Chairman and CEO said "In the three weeks since our initial offer, Valeant has recruite
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Cardiologists at Beaumont ... the Midwest,s first commercial implant of a device recently ... with non-valvular atrial fibrillation. The Watchman Left Atrial Appendage ... blood-thinning warfarin medication to reduce the risk of stroke. ... rhythm disorder affecting more than 5 million Americans. Twenty ...
(Date:3/26/2015)... 2015 Over-the-counter healthcare costs can be ... a new survey of store brand over-the-counter products ... cold to diabetes, can offer significant savings for ... the Private Label Manufacturers Association, assembled a market ... those essential for treatment of pre-diabetes and diabetes. ...
(Date:3/26/2015)... March 26, 2015 Zimmer Holdings, Inc. (NYSE ... ® Advanced Bearing Technology with Vitamin E by ... published earlier this month reported that, at 96 million ... Advanced Bearing Technology featuring Vitamin E grafted highly crosslinked ... wear rate reduction of 95 percent, with no cracking, ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... SAN DIEGO, Aug. 4, 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: ... for the quarter ended June 30, 2011. (Logo: ... for the second quarter of 2011 of $24.2 million, or ... as compared to a net loss for the second ...
... Dehaier Medical Systems Ltd. (Nasdaq: ... in the development, assembly, marketing and sale of medical ... that it will release financial results for the second ... Monday, August 15, 2011 before the start of trading ...
Cached Medicine Technology:Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results 2Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results 3Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results 4Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results 5Dehaier Medical to Report Second Quarter 2011 Financial Results on August 15 2
(Date:3/27/2015)... March 27, 2015 DrugDev announced company ... Easy was named to the 2015 Philadelphia Business Journal ... list spotlights 40 dynamic, up-and-coming leaders less than 40 ... involvement. Winners are honored at an awards program in ... Philadelphia Business Journal. , Lyn Kremer, Publisher of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 GenSight, ... it has appointed Sean Fitzgerald, a former technology and ... Operating Officer and Interim Chief Financial Officer. , Mr ... education technology innovator, EverFi, backed by Amazon founder and ... founder Evan Williams. Prior to EverFi, he was a ...
(Date:3/27/2015)... 2015 Operatic contenders and their avid ... April 17th. The universally acclaimed baritone Sherrill Milnes will ... Opera Idol at The Merion in Evanston. The event ... drawn aspiring opera singers from around the country. “This ... the finest young talent in the country,” said Margaret ...
(Date:3/27/2015)... Since September 2014, the country singer has been ... having been in retirement for a period of 13 years. ... return to touring, and concert events have been booking quickly ... sell out for the two shows recently scheduled for May ... the inventory of discounted Garth Brooks tickets for sale. , ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 “ VXi ... of its monthly Tech Report, which features the latest ... a technology expert and special reporter for NewsWatch, conducted ... an advanced noise-cancelling headset, eliminating 90% of ambient noise. ... while texts and emails are important to any professional, ...
Breaking Medicine News(10 mins):Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2
... , TORONTO, July 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals ... that its Board of Directors has authorized the Corporation ... pursuant to which the Corporation will offer to purchase ... common shares ("Shares") at a price of Cdn$0.20 (approximately ...
... ... healthcare associations to address high workforce shortage of lab professionals , ... Washington DC (PRWEB) July 17, 2009 ... based in Chicago, today announced it is joining the National Healthcare Career Network (NHCN). ...
... ... , ... July 17, 2009 -- Virtual classmates met face-to-face to celebrate the completion of their ... , ,Graduates gathered in Ophelia Parrish Performing Arts Center on the campus of Truman ...
... on tobacco and alcohol took place in June. The most popular ... 3.30 euros per packet. Are these taxes a form of dissuasion ... harm generated by those who smoke? A study by the Polytechnic ... the tobacco economy. The research, carried out by ...
... , , DALLAS, July 16 ... Baylor University Medical Center at Dallas (Baylor Dallas) in its America,s ... to achieve this distinction. , , ... Joel Allison, president and chief executive officer, Baylor Health Care System. ...
... , , , , ... a new technical assistance fact sheet on legal requirements relating to ... granting state licensure in occupations such as barbering, massage therapy and ... Persons with HIV and AIDS unfortunately still face obstacles ...
Cached Medicine News:Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 2Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 3Health News:Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid 4Health News:American Society for Clinical Pathology Joins the National Healthcare Career Network 2Health News:American Society for Clinical Pathology Joins the National Healthcare Career Network 3Health News:School of Health Management Honors 162 Graduating Students 2Health News:Is a society with smokers profitable? 2Health News:Is a society with smokers profitable? 3Health News:Baylor Dallas Recognized In U.S. News Media Group's 2009 - 2010 America's Best Hospitals 2Health News:Baylor Dallas Recognized In U.S. News Media Group's 2009 - 2010 America's Best Hospitals 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: